Table 1.
Baseline characteristics of the study population (52 ischaemic heart disease patients)
| Characteristic | Value |
|---|---|
| Age, mean (years) (range) | 71 (50–80) |
| Body mass index, mean (kg/m2) (range) | 29 (21–49) |
| Sex, n (%) | |
| Male | 32 (62) |
| Female | 20 (38) |
| Self reported history, n (%) | |
| Myocardial infarction | 25 (48) |
| Angina pectoris | 31 (60) |
| Arrhythmia | 26 (50) |
| Congestive heart failure | 13 (25) |
| Hypertension | 25 (48) |
| Stroke | 1 (2) |
| Diabetes | 10 (19) |
| Arthrosis | 11 (21) |
| Asthma | 7 (13) |
| Total cholesterol, mean (mmol/L) (SD) | 4.2 (0.8) |
| High-density lipoprotein cholesterol, mean (mmol/L) (SD) | 2.0 (3.0) |
| Medication, n (%) | |
| Statins | 43 (83) |
| Lipid-lowering medication | 47 (90) |
| Antithrombotic medication | 46 (88) |
| Regular use of β-blockers | 42 (81) |